These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17105999)

  • 1. Pharmacogenomics technique predicts chemotherapy success.
    Traynor K
    Am J Health Syst Pharm; 2006 Dec; 63(23):2304-6. PubMed ID: 17105999
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.
    Auman JT; McLeod HL
    Drug Metab Rev; 2008; 40(2):303-15. PubMed ID: 18464047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic profiling can predict chemotherapy side effects and treatment response.
    Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How not to treat cancer.
    Schilsky RL
    Lancet Oncol; 2008 Jun; 9(6):504-5. PubMed ID: 18510981
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CINSARC signature: prognostic and predictive of response to chemotherapy?
    Bertucci F; Finetti P; Sabatier R; Birnbaum D
    Cell Cycle; 2010 Oct; 9(19):4025-7. PubMed ID: 20978372
    [No Abstract]   [Full Text] [Related]  

  • 8. Do predictive signatures really predict response to cancer chemotherapy?
    Borst P; Wessels L
    Cell Cycle; 2010 Dec; 9(24):4836-40. PubMed ID: 21150277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
    Cosler LE; Lyman GH
    Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
    [No Abstract]   [Full Text] [Related]  

  • 10. New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
    Nair S; LLerena A
    Drug Metab Pers Ther; 2018 Jun; 33(2):61-64. PubMed ID: 29688886
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer pharmacogenomics: do cancer cell lines have the right stuff?
    Auman JT
    Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522
    [No Abstract]   [Full Text] [Related]  

  • 12. Microarrays in pharmacogenomics.
    Chen JJ
    J Biopharm Stat; 2004 Aug; 14(3):535-7. PubMed ID: 15468750
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and back.
    Franklin WA; Carbone DP
    Lung Cancer; 2003 Aug; 41 Suppl 1():S147-54. PubMed ID: 12867073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacogenomics and transcriptional profiling in early phase oncology clinical trials.
    Burczynski ME; Oestreicher JL; Cahilly MJ; Mounts DP; Whitley MZ; Speicher LA; Trepicchio WL
    Curr Mol Med; 2005 Feb; 5(1):83-102. PubMed ID: 15720272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
    Robert J
    J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in molecular analysis for individualized cancer therapy.
    Clynes M; O'Connor R; O'Driscoll L; Daly C; Meleady P
    Drug Discov Today; 2003 Jun; 8(12):531. PubMed ID: 12821298
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploring the human genome in cancer with genomic approaches.
    Scheel JR; Kuo MD
    J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene expression profiling of treatment resistance: hype or hope for therapeutic target identification.
    Helleman J; Jansen MP; Berns EM
    Int J Gynecol Cancer; 2006; 16 Suppl 2():538-42. PubMed ID: 17010068
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.